Biological E, a pharmaceutical company, is planning to undertake a significant expansion project for their pharma plant in Kolthur, Shameerpet, Medchal-Malkajgiri, Telangana. The primary objective of the project is to increase the production capacity of their active pharmaceutical ingredients (API) products by introducing new products such as anidulfungin (1987 Kg/Annum), dalbavancin (691 Kg/Annum), daptomycin (7776 Kg/Annum), and others. The expansion project is estimated to cost around Rs.1231.606 million, and it is a substantial investment for Biological E. The company is committed to expanding their manufacturing capabilities to meet the growing demand for their products and to maintain their position as a leading pharmaceutical company. In February 2023, Biological E received consent from the state pollution control authorities to establish the project. This is a significant milestone in the project’s progress, and it enables the company to move forward with the construction and implementation of the expansion plan. The company will likely engage in various activities, including site preparation, construction, equipment procurement, and hiring of personnel, among others
For more details of this project : Rs.1231 Million Pharma Plant Expansion Project in Medchal-Malkajgiri, Telangana
